close
close

Conic reports positive data from real-world multiple sclerosis studies

Posted on by darion

Data published in the International Journal of MS Care details how Cionic’s neural sleeve was able to use a proprietary array-based stimulation approach to address the challenges of neuromuscular walking. Source: Shutterstock/CC7

California-based clothing company Cionic has published the results of a real-world study that shows that Neural Sleeve assistive technology has a positive impact on the well-being of patients suffering from multiple sclerosis (MS).

Data published in the International Journal of MS Care details how Cionic’s neural sleeve was able to use a proprietary array-based stimulation approach to address the challenges of neuromuscular walking while improving patient mobility.

The study, titled “Influence of the Cionic Neural Sheath on Ankle Kinematics During Gait in Multiple Sclerosis,” examined two key indicators related to walking difficulties. These include decreased dorsiflexion or difficulty lifting the foot and increased inversion, as well as a tendency for the ankle and foot to roll inward.

The results of the study showed that when using the Cionic Neural Sleeve Stimulation Device, all participants experienced improved dorsiflexion and decreased inversion, providing greater freedom of movement of the foot and ankle.

Jeremiah Robison, CEO of Cionic, said: “To meet the highly individualized and complex mobility challenges of people with neurological conditions, it is critical to have a flexible technology system that continuously interprets their movement and muscle activity and adapts to their needs.

“These results demonstrate the tremendous power of our software-controlled neuromodulation system and real-time adaptive algorithms to improve walking in people with multiple sclerosis.”

Access the most comprehensive company profiles on the market, powered by GlobalData. Save hours of research. Gain a competitive advantage.

Company Profile – free sample

You will receive a download email shortly

We are sure of the exceptional quality of our company profiles. However, we want you to make the most beneficial decision for your business, which is why we offer a free sample, which you can download by submitting the form below

By GlobalData







Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information about your rights in relation to your personal data and how you can unsubscribe from future subscriptions marketing messages. Our services are intended for corporate subscribers and you warrant that the email address you submit is your corporate email address.

The positive study results come almost a year after the company raised $12 million in a Series A extension financing round to further develop the U.S. Food and Drug Administration (FDA)-approved Neural Sleeve.

Doug Wadja, lead author of the study, added: “Our findings highlight the effectiveness of a comprehensive technology that can simultaneously address a broader spectrum of gait disorders. It was encouraging that all participants experienced improvements in two key indicators of safe walking.”

In other areas of multiple sclerosis treatment, Phillips has partnered with Swedish software company Synthetic MR to develop artificial intelligence (AI)-based quantitative brain imaging tools.